Form4insider filings, from the source

SEC Form 4 · accession 0000904454-16-001105

Syndax Pharmaceuticals Inc · SNDX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jesse I Treu
10% Owner
James C Blair
10% Owner
Brian H Dovey
10% Owner
Brian K Halak
10% Owner
Period of report
Mar 8, 2016
Accepted (ET)
Mar 8, 2016 · 11:31 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001395937

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3,F4,F5,F6Mar 8, 2016C761,062—A761,062D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series B-1 Preferred StockF2,F3,F4,F5,F6,F1—Mar 8, 2016C400,422D——Common Stock400,4220D
Series C-1 Preferred StockF2,F3,F4,F5,F6,F1—Mar 8, 2016C360,640D——Common Stock360,6400D

Explanation of responses